Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

Find Out More
University of Liverpool Featured PhD Programmes
University of Oxford Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
Imperial College London Featured PhD Programmes
University College London Featured PhD Programmes
"glioblastoma"×
10 miles
    2. >
    3. >

glioblastoma PhD Projects, Programs & Scholarships

We have 12 glioblastoma PhD Projects, Programs & Scholarships

  • "glioblastoma" ×
  • clear all
Order by 
Showing 1 to 10 of 12
  Non-canonical G protein signalling of US28 as a new target for glioblastoma
Queen’s University Belfast School of Medicine, Dentistry & Biomedical Sciences
  Research Group: Centre for Experimental Medicine
  Dr B Plouffe, Dr E Evergren, Prof C Taggart
Application Deadline: 20 January 2019
Glioblastoma (GBM) is a very aggressive type of brain cancer with an extremely poor prognosis. For most of GBM cases, infection by the human cytomegalovirus (HCMV) expressing the chemokine receptor US28 is responsible of this disease.
Details
Type/Funding
  Role of hypoxia in promotion of higher grade glioblastoma
University of Bradford Faculty of Life Sciences
  Research Group: Institute of Cancer Therapeutics
  Dr V Vinader, Dr K Afarinkia
Applications accepted all year round
Glioblastomas are categorized into four grades. Grade I is essentially benign and slow growing, and most amenable to treatment. Grade II tumors are larger and invade surrounding tissue.
Details
Type/Funding
  MRC Precision Medicine DTP: Mapping the transcriptomic, genomic and breakomic landscape of radiation resistance in pancreatic carcinoma and glioblastoma
University of Glasgow College of Medicine, Veterinary and Life Sciences
  Research Group: Institute of Cancer Sciences
  Dr D Chang, Dr R Carruthers
Application Deadline: 7 January 2019
Supervisors. Dr David Chang. Dr Ross Carruthers. PhD project summary. The determinants of response to radiotherapy in common tumour sites remain largely enigmatic, with no clinically useful biomarkers of radiation sensitivity being available.
Details
Type/Funding
  MRC DiMeN Doctoral Training Partnership: Gene expression network analysis to identify candidate drivers of treatment resistance in glioblastoma multiforme
University of Leeds MRC DiMeN Doctoral Training Partnership
  Dr A Droop, Dr L Stead, Prof D R Westhead
Application Deadline: 21 January 2019
Glioblastoma (GBM) is an incurable brain cancer. Patients survive an average 14 months post-diagnosis, despite receiving surgery and intensive chemoradiation because 100% of tumours grow back.
Details
Type/Funding
  The IGF axis as a mediator of treatment resistance in glioblastoma multiforme
University of Oxford Department of Oncology
  Prof V Macaulay, Prof N Sibson
Application Deadline: 11 January 2019
Despite multimodality treatment with surgery, ionising radiation (IR) and chemotherapy, the outlook for patients with glioblastoma multiforme (GBM) is extremely poor.
Details
Type/Funding
  Development of novel inhibitors for the treatment of Glioblastomas
University of Sunderland School of Pharmacy and Pharmaceutical sciences
  Dr S Ahmed, Dr S Darby
Applications accepted all year round
Glioblastoma (GBM) is the most common form of brain tumour in adults and is incurable. Despite optimal treatment consisting of surgery, chemotherapy and radiotherapy, median survival is 15 month.
Details
Type/Funding
  MRC Precision Medicine DTP: Quantitative proteomic analysis of dysregulated adhesion protein localisation in patient-derived cancer cells
University of Edinburgh College of Medicine and Veterinary Medicine
  Research Group: Edinburgh Cancer Research Centre
  Dr A Byron, Prof M Frame, Prof R Zubarev, Dr A Sims
Application Deadline: 7 January 2019
Summary. This project seeks to use proteomic data and computational approaches to identify signatures of cell adhesion proteins that are mislocalised in cells from brain cancer patients.
Details
Type/Funding
  MRC DiMeN Doctoral Training Partnership: Development and application of fast Magnetic Resonance Spectroscopic Imaging methods for neuro-chemical profiling
University of Leeds MRC DiMeN Doctoral Training Partnership
  Prof J Schneider, Dr S Short
Application Deadline: 21 January 2019
While Magnetic Resonance Imaging is well established to assess anatomy, structure and function in patients and in animal models of human disease alike, (routine) MR Spectroscopy tools to investigate metabolic alterations are far less common.
Details
Type/Funding
  How does amino acid metabolism affect tumour growth?
Peter MacCallum Cancer Centre Sir Peter MacCallum Department of Oncology, University of Melbourne
  Dr L. Cheng
Applications accepted all year round
The effect of diet on tumour growth is hotly debated but poorly characterized. Due to the heterogeneous nature of the tumours, dietary studies in patients with varied genetic background often led to inconclusive outcome.
Details
Type/Funding
  Understanding the molecular mechanisms which drive brain cancer recurrence and defining novel therapies to target these aggressive tumour cell populations
QIMR Berghofer Medical Research Institute Medical Research
  Dr B Day
Application Deadline: 30 April 2019
Glioblastoma (GBM) is the most common and aggressive adult primary brain cancer. Median survival is. As part of the QIMR-Berghofer Brain Cancer Tissue Bank, we have collected a series of patient specimens which include primary tumours that have not undergone treatment and matching post-treatment recurrent tumours.
Details
Type/Funding
Show 10 15 30 per page
4k+

PhD Project & Programmes
Search for PhDs
PhDs by Subject
PhDs by Institution
PhDs by Country
PhDs by Email
Info for students
Postgraduate Open Days
PhD Study Guides
PhD Study Abroad
Funding Your PhD
Postgraduate Advice Forum
Postgraduate Email Updates
Info for advertisers
Advertise your PhD Project & Programmes
Provider Login
Display Advertising
Targeted Emails

FindAPhD. Copyright 2005-2018
All rights reserved.

Meet with top universities

Get funding advice

Win a £1,000 bursary